51
Participants
Start Date
March 31, 2002
Primary Completion Date
May 31, 2003
epothilone b
intravenous 2.5 mg/m2 as a 5 minutes bolus infusion once every week for three weeks followed by one week off
UPMC Health Systems, Pittsburgh
Duke University Medical Center, Durham
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Oklahoma Oncology, Inc., Tulsa
University of Colorado, Aurora
Comprehensive Cancer Center@ Our Lady if Mercy Medical Center, The Bronx
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY